Clinical Trial Update: Use of Stress-CMR Using Regadenoson and GE-267 in Adult Patients with Known or Suspected Coronary Artery Disease

View source ↗

Summary

A clinical trial update describing a planned study of pharmacologic stress-testing using regadenoson and GE-267 in adults with known or suspected coronary arter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• GE-267 (GE-267)
• Regadenoson (Regadenoson)

Snippet

Sponsor: German Heart Institute | Conditions: Coronary Artery Disease | Status: NOT_YET_RECRUITING